Absci (ABSI) Amortizatization of Intangibles (2022 - 2026)

Absci's (ABSI) quarterly Amortizatization of Intangibles came in at $421000.0 in Q1 2026, down 39.77% year-on-year from $699000.0 in Q1 2025, and down 20.11% quarter-over-quarter from $527000.0 in Q4 2025.

Absci (ABSI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Absci has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $421000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $421000.0, down 39.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 40.57% YoY), and the FY2025 annual result was $2.5 million, down 32.06% from the prior year.
  • Amortizatization of Intangibles came in at $421000.0 for Q1 2026 at Absci, down from $527000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q2 2024 to a low of $396000.0 in Q4 2023.
  • The 5-year median for Amortizatization of Intangibles is $678500.0 (2022), against an average of $719000.0.
  • Across the five-year window, Amortizatization of Intangibles surged 97.47% in 2024 and slumped 44.8% in 2025, its largest moves.
  • Absci's Amortizatization of Intangibles stood at $688000.0 in 2022, then plunged by 42.44% to $396000.0 in 2023, then soared by 97.47% to $782000.0 in 2024, then plunged by 32.61% to $527000.0 in 2025, then decreased by 20.11% to $421000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $421000.0 (Q1 2026), $527000.0 (Q4 2025), and $648000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - 421,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 421,000.00
Mar 31, 2026 421,000.00
Dec 31, 2025 527,000.00
Dec 31, 2025 527,000.00
Sep 30, 2025 648,000.00
Sep 30, 2025 648,000.00
Jun 30, 2025 669,000.00
Jun 30, 2025 669,000.00
Mar 31, 2025 699,000.00
Mar 31, 2025 699,000.00
Dec 31, 2024 782,000.00
Dec 31, 2024 782,000.00
Sep 30, 2024 1.12 Mn
Sep 30, 2024 1.12 Mn
Jun 30, 2024 1.21 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 631,000.00
Mar 31, 2024 631,000.00
Dec 31, 2023 396,000.00
Dec 31, 2023 396,000.00